Bendamustine is a nitrogen mustard drug indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophili...
Bendamustine is indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States
Duke University Medical Center - Division of Hematologic Malignancies, Durham, North Carolina, United States
Stanford University, Stanford, California, United States
Sun Yat-sen University Cancer Center, Guangzhou, Please Select, China
Mercy Clinic Cancer & Hematology - Chub O'Reilly Cancer Center, Springfield, Missouri, United States
Community Cancer Trials of Utah, Ogden, Utah, United States
Centre intégré universitaire de santé et de services sociaux de l'Estrie, Sherbrooke, Quebec, Canada
Local Institution - 008, Baltimore, Maryland, United States
Local Institution - 009, Duarte, California, United States
Local Institution - 011, New York, New York, United States
University of Alabama, Birmingham, Alabama, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
UF Health Shands Cancer Hospital, Gainesville, Florida, United States
Princess Margaret Hospital (Ontario), Toronto, Ontario, Canada
Community Health Network, Indianapolis, Indiana, United States
Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
University of Iowa, Iowa City, Iowa, United States
Stanford Cancer Institute, Palo Alto, California, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.